Inside EE’s New Research Roadmap for the Final 10%
At Emily’s Entourage’s inaugural State of the Science: EE Edition webinar, we unveiled a bold new Research Roadmap—and shared why years of... Read More
Inside EE’s Newest Research Grants: Tackling the Barriers to CF Breakthroughs
Six newly funded projects are pursuing promising solutions to some of the field’s toughest challenges for the final 10%. Getting gene-editing... Read More
Emily’s Entourage Breaks New Ground with AI-Powered Grant to Identify Next-Generation CF Gene Therapy Delivery Systems
AI-guided lipid nanoparticle screening aims to overcome longstanding barriers to inhaled CF gene therapy Lower Merion, PA—September 9, 2026—Emily’s Entourage (EE), an... Read More
New Emily’s Entourage Grant to Fund Novel Phage-Based Therapy for Drug-Resistant Infections in Cystic Fibrosis
Inhaled bacteriophage-antibiotic combination could offer a new treatment approach for persistent, antibiotic-resistant lung infections Lower Merion, PA—September 3, 2026—Emily’s Entourage (EE), an... Read More
Emily’s Entourage Funds Novel Therapy to Target MRSA Lung Infections in Cystic Fibrosis
Inhaled vancomycin–DNase combination aims to overcome biofilms and improve treatment for persistent MRSA infections Lower Merion, PA—August 24, 2026—Emily’s Entourage (EE), an... Read More
New 2026 Emily’s Entourage Translational Research Grant to Develop Mucus-Penetrating Gene Editing Delivery for Cystic Fibrosis
Engineered lipid nanoparticles designed to overcome the cystic fibrosis mucus barrier could enable targeted gene editing through inhalation Lower Merion, PA—August 18,... Read More
Emily’s Entourage Funds Synthetic Biology Approach to Enable Durable Gene Therapy for Cystic Fibrosis
Engineered synthetic receptor technology aims to selectively expand corrected airway stem cells and improve long-term treatment durability. Lower Merion, PA—August 13, 2026—Emily’s... Read More
Emily’s Entourage Appoints David A. Waltz, MD, as First Chief Medical Officer
Veteran cystic fibrosis physician-scientist and former Vertex Pharmaceuticals senior leader to help accelerate therapies for the final 10% of people with cystic... Read More
#MadeThisWay: How We’re Claiming Rare During Rare Disease Week 2026
At Emily’s Entourage (EE), rare isn’t something we tiptoe around. It isn’t something to soften, explain away, or make smaller so it’s... Read More
NACFC 2025: Key Takeaways for the Final 10%
By Chandra Ghose, PhD, Chief Scientific Officer at Emily’s Entourage From the misty shores of Puget Sound to the buzzing halls of... Read More
